Skip to main content
OpenTrials
Completed

NCT Number: NCT03882294

Probiotics and Its Associated Factors on Aflatoxin Biomarkers

The study will be aimed to investigate the effect of probiotic intervention and its associated factors on aflatoxin biomarkers among healthy subjects in Serdang and Kajang, Selangor

Completed

Looking for future studies?

Notify Me

Key information

Age range

20 year–60 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Teaching Hospital Universiti Putra Malaysia

Serdang, Malaysia

About this study

The study will be a randomized, double-blind, placebo-controlled, parallel intervention that conducted for 12 weeks and followed-up for 4 weeks among healthy adults under living condition in Serdang and Kajang, Selangor. 164 subjects will be recruited for the intervention study, where 82 subjects will be randomly allocated to the probiotic or placebo group. Probiotic and placebo drinks (80 ml) will be prepared in the form of bottle. Placebo drink will have similar taste, colour, physical appearance, and nutritional value as probiotic drink but contain no LcS. Morning urine samples (15 ml), weight status, and dietary intake will be collected every two weeks from week 0 to week 12 and follow up until week 16 at community centre. Whereas, fasting blood samples (5 ml) and physical activity will be collected every four weeks for 16 weeks at the community centre.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Malaysian healthy male or female adults (BMI <30kg/m2) aged 20 to 60 years who have regular bowel movement (at least 4 times/week), AFB1 >4.71 pg/mg albumin, and AFM1 > 0.88 ng/ml

Exclusion criteria

  • History or presence of any clinically important disease or disorder (eg. cardiovascular disease, kidney disease, diabetes mellitus, etc.) which, in the opinion of the investigator, may either put the subject at risk because of participation in the study, or influence the results or the subject's ability to participate in the study
  • Mental status that is incompatible with the proper conduct of the study
  • Functional constipation [based on Rome III diagnostic criteria with a five-point symptoms based diagnosing tool (0=never or rarely, 1=sometimes, 2=often, 3=most of the time, 4=always)]
  • Diarrhoea within 2 months prior to the study start
  • Allergic reaction towards probiotic, milk and with gastric problem
  • Lactose intolerance
  • Use of medications or/and antibiotics
  • Use of probiotic, prebiotic and fibre supplements or/and laxatives during the two weeks prior to study start.
  • Drug/alcohol abuse (for alcohol 4 times/day or 20 times/week)
  • Pregnant
  • Reported special diets such as vegetarian, vegan, or macrobiotic
  • Festive (eg. Ramadan, Chinese New Year etc) 3 months before and during the study
  • Participation in another intervention study one month prior to the present study

Treatment and study plan

Probiotics

Other

Participants will be requested to consume the drinks (80 ml) twice a day - after lunch and dinner for 12 weeks.

Placebo

Other

Participants will be requested to consume the drinks (80 ml) twice a day - after lunch and dinner for 12 weeks.

Primary outcomes

  1. Changes in serum AFB1-lysine adducts (pg/mg albumin) over 16 weeks

    Time frame: From week 0 to week 16

    Analysis of serum AFB1-lysine adducts will be done using elisa kit through HPLC.

  2. Changes in urinary AFM1 (ng/ml) over 16 weeks

    Time frame: From week 0 to week 16

    Analysis of urinary AFM1 will be done using elisa kit.

Secondary outcomes

  1. Changes in body mass index (kg/m^2) over 16 weeks

    Time frame: From week 0 to week 16

    Changes in weight and height will be measured using weighing scale and body meter respectively. Weight and height will be combined to report BMI in kg/m^2

  2. Changes in waist circumference (cm) over 16 weeks

    Time frame: From week 0 to week 16

    The parameter will be measured using measuring tape.

  3. Changes in physical activity level (MET-min/week) over 16 weeks

    Time frame: From week 0 to week 16

    The parameter will be examined using questionnaire based on the Global Physical Activity Questionnaire.

  4. Changes in dietary intake over 16 weeks

    Time frame: From week 0 to week 16

    Dietary assessment will be recorded via food frequency questionnaire (FFQ). The conversion of food frequency to the amount of food intake is carried out using the following formula:

    Amount of food (g/day) = frequency of intake (conversion factor) × serving size × total of serving × weight of food in one serving (Wessex Institute of Public Health, 1995).

  5. Changes in knowledge, attitude and practice (KAP) on aflatoxin over 16 weeks

    Time frame: From week 0 to week 16

    KAP will be examined using questionnaire in bilingual (English and Bahasa Malaysia). Knowledge towards aflatoxin is scored into two groups: know and do not know. Attitudes and practices are categorized using likert scale with 1=strongly disagree, 2=disagree, 3=agree and 4=strongly agree.

Sponsors and collaborators

Lead sponsor

Universiti Putra Malaysia

Other

Registry information

Official study title

Effect of Probiotics and Its Associated Factors on Aflatoxin Biomarkers Among Healthy Subjects in Serdang and Kajang, Selangor: A Twelve-week Intervention

Important dates

Study start
2020
Primary completion
2021
Study completion
2021
First posted
Mar 20, 2019
Registry last updated
Jun 21, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.